US6217911B1
(en)
|
1995-05-22 |
2001-04-17 |
The United States Of America As Represented By The Secretary Of The Army |
sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
|
US5693343A
(en)
|
1984-03-16 |
1997-12-02 |
The United States Of America As Represented By The Secretary Of The Army |
Microparticle carriers of maximal uptake capacity by both M cells and non-M cells
|
USRE40786E1
(en)
|
1984-03-16 |
2009-06-23 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres
|
US6309669B1
(en)
|
1984-03-16 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
|
US6410056B1
(en)
|
1984-03-16 |
2002-06-25 |
The United States Of America As Represented By The Secretary Of The Army |
Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
|
NZ217821A
(en)
*
|
1985-10-10 |
1989-07-27 |
Biotech Australia Pty Ltd |
Oral delivery system; complex of active agent and vitamin b12 or analogue thereof
|
US6024983A
(en)
*
|
1986-10-24 |
2000-02-15 |
Southern Research Institute |
Composition for delivering bioactive agents for immune response and its preparation
|
US5807832A
(en)
*
|
1987-06-09 |
1998-09-15 |
Biotech Australia Pty Limited |
Oral delivery of biologically active substances bound to vitamin B12
|
US5116612A
(en)
*
|
1987-06-23 |
1992-05-26 |
Allergy Immuno Technologies, Inc. |
Immunotherapy agents for treatment of IgE mediated allergies
|
AU639903B2
(en)
*
|
1989-01-20 |
1993-08-12 |
University Of Melbourne, The |
Fibrinolysis
|
CA2045574A1
(en)
*
|
1989-01-20 |
1990-07-21 |
John A. Hamilton |
Fibrinolysis
|
US4990336A
(en)
*
|
1989-02-08 |
1991-02-05 |
Biosearch, Inc. |
Sustained release dosage form
|
DK0471036T4
(da)
*
|
1989-05-04 |
2004-07-19 |
Southern Res Inst |
Indkapslingsfremgangsmåde
|
US6126945A
(en)
*
|
1989-10-03 |
2000-10-03 |
Pharmacia Ab |
Tumor killing effects of enterotoxins, superantigens, and related compounds
|
DK546289D0
(da)
*
|
1989-11-02 |
1989-11-02 |
Danochemo As |
Carotenoidpulvere
|
WO1991006287A1
(en)
*
|
1989-11-06 |
1991-05-16 |
Enzytech, Inc. |
Protein microspheres and methods of using them
|
SG46225A1
(en)
*
|
1990-04-24 |
1998-02-20 |
Flustat Pty Limited |
Oral vaccine comprising antigen surface-associated with red blood cells
|
US5882649A
(en)
*
|
1990-04-24 |
1999-03-16 |
Flustat Pty. Ltd. |
Oral vaccine comprising antigen surface-associated with red blood cells
|
US5780012A
(en)
*
|
1990-06-21 |
1998-07-14 |
Huland; Edith |
Method for reducing lung afflictions by inhalation of cytokine solutions
|
DE59007645D1
(de)
*
|
1990-06-21 |
1994-12-08 |
Edith Dr Huland |
Verwendung zytokinhaltiger Aerosole und zytokinhaltige Aerosole selbst.
|
ZA922425B
(en)
*
|
1991-04-02 |
1993-02-24 |
Biotech Australia Pty Ltd |
Oral delivery systems for microparticles
|
WO1992019263A1
(en)
|
1991-04-24 |
1992-11-12 |
The United States Of America, As Represented By The Secretary Of The Army |
Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
US5283066A
(en)
*
|
1992-02-19 |
1994-02-01 |
Development Center For Biotechnology |
Method of stimulating an immune response by using a hapten
|
US5352461A
(en)
*
|
1992-03-11 |
1994-10-04 |
Pharmaceutical Discovery Corporation |
Self assembling diketopiperazine drug delivery system
|
US6235313B1
(en)
|
1992-04-24 |
2001-05-22 |
Brown University Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
US6197346B1
(en)
|
1992-04-24 |
2001-03-06 |
Brown Universtiy Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
US5922340A
(en)
*
|
1992-09-10 |
1999-07-13 |
Children's Medical Center Corporation |
High load formulations and methods for providing prolonged local anesthesia
|
US5618563A
(en)
*
|
1992-09-10 |
1997-04-08 |
Children's Medical Center Corporation |
Biodegradable polymer matrices for sustained delivery of local anesthetic agents
|
US5700485A
(en)
|
1992-09-10 |
1997-12-23 |
Children's Medical Center Corporation |
Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
|
WO1994007469A1
(en)
*
|
1992-09-25 |
1994-04-14 |
Dynagen, Inc. |
An immunobooster for delayed release of immunogen
|
AU5669894A
(en)
*
|
1992-11-16 |
1994-06-08 |
Corporation Of Mercer University |
Compositions using microencapsulated neutralizing antibodies
|
CA2086631C
(en)
*
|
1992-12-22 |
1998-10-06 |
J. Gabriel Michael |
Oral administration of immunologically active biomolecules and other therapeutic proteins
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6939546B2
(en)
|
1993-05-21 |
2005-09-06 |
The United States Of America As Represented By The Secretary Of The Army |
Model for testing immunogenicity of peptides
|
US5603960A
(en)
*
|
1993-05-25 |
1997-02-18 |
O'hagan; Derek T. |
Preparation of microparticles and method of immunization
|
US5562909A
(en)
*
|
1993-07-12 |
1996-10-08 |
Massachusetts Institute Of Technology |
Phosphazene polyelectrolytes as immunoadjuvants
|
US6004534A
(en)
*
|
1993-07-23 |
1999-12-21 |
Massachusetts Institute Of Technology |
Targeted polymerized liposomes for improved drug delivery
|
WO1995003035A1
(en)
*
|
1993-07-23 |
1995-02-02 |
Massachusetts Institute Of Technology |
Polymerized liposomes with enhanced stability for oral delivery
|
WO1995011009A1
(en)
*
|
1993-10-22 |
1995-04-27 |
Genentech, Inc. |
Method for preparing microspheres comprising a fluidized bed drying step
|
ATE223702T1
(de)
*
|
1993-10-22 |
2002-09-15 |
Genentech Inc |
Verfahren und zusammensetzungen zur mikrokapselung von adjuvantien
|
CA2172509C
(en)
*
|
1993-10-22 |
2010-08-24 |
Jeffrey L. Cleland |
Methods and compositions for microencapsulation of antigens for use as vaccines
|
US6080429A
(en)
*
|
1993-10-25 |
2000-06-27 |
Genentech, Inc. |
Method for drying microspheres
|
US5643605A
(en)
*
|
1993-10-25 |
1997-07-01 |
Genentech, Inc. |
Methods and compositions for microencapsulation of adjuvants
|
US6913767B1
(en)
|
1993-10-25 |
2005-07-05 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines
|
RU2178695C2
(ru)
*
|
1993-11-19 |
2002-01-27 |
Жансен Фармасетика Н.В. |
Микрокапсулы, содержащие рисперидон, фармацевтическая композиция и способы их получения
|
US5902565A
(en)
*
|
1993-12-24 |
1999-05-11 |
Csl Limited |
Spray dried vaccine preparation comprising aluminium adsorbed immunogens
|
US6531156B1
(en)
|
1994-04-15 |
2003-03-11 |
Temple University |
Aqueous solven encapsulation method, apparatus and microcapsules
|
US5876735A
(en)
*
|
1994-04-22 |
1999-03-02 |
Corixa Corporation |
Methods for enhancement of protective immune responses
|
US6013268A
(en)
|
1994-04-22 |
2000-01-11 |
Corixa Corporation |
Methods for enhancement of protective immune responses
|
US6447796B1
(en)
|
1994-05-16 |
2002-09-10 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
US6855331B2
(en)
|
1994-05-16 |
2005-02-15 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
US5571531A
(en)
*
|
1994-05-18 |
1996-11-05 |
Mcmaster University |
Microparticle delivery system with a functionalized silicone bonded to the matrix
|
US20030026782A1
(en)
*
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US5821226A
(en)
*
|
1994-12-01 |
1998-10-13 |
Oklahoma Medical Research Foundation |
BAL C-tail drug delivery molecules
|
US5696087A
(en)
*
|
1994-12-01 |
1997-12-09 |
Oklahoma Medical Research Foundation |
Method and compositions for reducing cholesterol absorption
|
US5681819A
(en)
*
|
1994-12-01 |
1997-10-28 |
Oklahoma Medical Research Foundation |
Method and compositions for reducing cholesterol absorption
|
US6902743B1
(en)
|
1995-05-22 |
2005-06-07 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
|
US7033608B1
(en)
|
1995-05-22 |
2006-04-25 |
The United States Of America As Represented By The Secretary Of The Army |
“Burst-free” sustained release poly-(lactide/glycolide) microspheres
|
NZ311474A
(en)
|
1995-06-09 |
1997-09-22 |
Euro Celtique Sa |
Formulations for providing prolonged local anesthesia
|
JPH11510142A
(ja)
|
1995-07-21 |
1999-09-07 |
ブラウン・ユニバーシティ・リサーチ・ファンデーション |
核酸負荷ポリマー微粒子を使用した遺伝子治療法
|
US6143211A
(en)
*
|
1995-07-21 |
2000-11-07 |
Brown University Foundation |
Process for preparing microparticles through phase inversion phenomena
|
US6248720B1
(en)
|
1996-07-03 |
2001-06-19 |
Brown University Research Foundation |
Method for gene therapy using nucleic acid loaded polymeric microparticles
|
ATE337399T1
(de)
|
1995-09-01 |
2006-09-15 |
Corixa Corp |
Zusammensetzungen zur immuntherapie und diagnose von tuberculosis
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
EP0965336A1
(en)
*
|
1995-11-09 |
1999-12-22 |
Microbiological Research Authority |
Microencapsulated DNA for gene therapy
|
US5985312A
(en)
*
|
1996-01-26 |
1999-11-16 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
US6368586B1
(en)
|
1996-01-26 |
2002-04-09 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
US6342218B1
(en)
|
1997-02-14 |
2002-01-29 |
Oklahoma Medical Research Foundation |
Method for treatment of SLE
|
US6015576A
(en)
*
|
1997-08-29 |
2000-01-18 |
Bio-Sphere Technology, Inc. |
Method for inducing a systemic immune response to an antigen
|
US6207185B1
(en)
|
1996-03-22 |
2001-03-27 |
Bio-Sphere Technology |
Method for inducing a systemic immune response to an HIV antigen
|
US6117449A
(en)
*
|
1996-03-22 |
2000-09-12 |
Bio-Sphere Technology, Inc. |
Method for inducing a systemic immune response to a hepatitis antigen
|
US6652837B1
(en)
|
1996-05-24 |
2003-11-25 |
Massachusetts Institute Of Technology |
Preparation of novel particles for inhalation
|
US5874064A
(en)
*
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US5985309A
(en)
*
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
US20020052310A1
(en)
|
1997-09-15 |
2002-05-02 |
Massachusetts Institute Of Technology The Penn State Research Foundation |
Particles for inhalation having sustained release properties
|
AU733867B2
(en)
|
1996-06-24 |
2001-05-31 |
Euro-Celtique S.A. |
Methods for providing safe local anesthesia
|
US5955096A
(en)
*
|
1996-06-25 |
1999-09-21 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
|
US6344202B1
(en)
*
|
1996-07-12 |
2002-02-05 |
University Of Manitoba |
DNA immunization against chlaymdia infection
|
US5980948A
(en)
*
|
1996-08-16 |
1999-11-09 |
Osteotech, Inc. |
Polyetherester copolymers as drug delivery matrices
|
US6046187A
(en)
|
1996-09-16 |
2000-04-04 |
Children's Medical Center Corporation |
Formulations and methods for providing prolonged local anesthesia
|
US5783567A
(en)
*
|
1997-01-22 |
1998-07-21 |
Pangaea Pharmaceuticals, Inc. |
Microparticles for delivery of nucleic acid
|
PT1005374E
(pt)
*
|
1997-01-22 |
2007-07-18 |
Mgi Pharma Biolog Inc |
Micropartículas para administração de ácido nucleico
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
BR9807332A
(pt)
|
1997-02-12 |
2000-10-31 |
Corixa Corp |
Antìgenos de leishmania para utilização na terapia e diagnóstico de leishmaniose
|
US6261562B1
(en)
|
1997-02-25 |
2001-07-17 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
EP1003501B9
(en)
|
1997-04-02 |
2005-06-08 |
The Brigham And Women's Hospital, Inc. |
Use of an agent for lowering the risk of cardiovascular disease
|
ZA982968B
(en)
|
1997-04-09 |
1998-10-27 |
Corixa Corp |
Compositions and methods for the treatment and diagnosis of breast cancer
|
US6060082A
(en)
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
BR9815499A
(pt)
|
1997-07-02 |
2001-01-02 |
Euro Celtique Sa |
Anestesia prolongada nas juntas e nos espacos corporais.
|
EP1579851A3
(en)
*
|
1997-08-29 |
2009-09-02 |
Corixa Corporation |
Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of use thereof
|
WO1999009956A1
(en)
*
|
1997-08-29 |
1999-03-04 |
Corixa Corporation |
Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of using thereof
|
US7052678B2
(en)
|
1997-09-15 |
2006-05-30 |
Massachusetts Institute Of Technology |
Particles for inhalation having sustained release properties
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6946117B1
(en)
|
1997-09-29 |
2005-09-20 |
Nektar Therapeutics |
Stabilized preparations for use in nebulizers
|
US6013258A
(en)
*
|
1997-10-09 |
2000-01-11 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
US6183746B1
(en)
*
|
1997-10-09 |
2001-02-06 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
US6197229B1
(en)
*
|
1997-12-12 |
2001-03-06 |
Massachusetts Institute Of Technology |
Method for high supercoiled DNA content microspheres
|
US7393630B2
(en)
|
1997-12-16 |
2008-07-01 |
Novartis Vaccines And Diagnostics, Inc. |
Use of microparticles combined with submicron oil-in-water emulsions
|
CA2314934C
(en)
*
|
1997-12-16 |
2006-08-29 |
Chiron Corporation |
Use of microparticles combined with submicron oil-in-water emulsions
|
EP1042360A2
(en)
|
1997-12-24 |
2000-10-11 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
|
US20020147143A1
(en)
|
1998-03-18 |
2002-10-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
EP2003201A3
(en)
|
1998-03-18 |
2008-12-31 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
CN1163602C
(zh)
|
1998-04-07 |
2004-08-25 |
科里克萨公司 |
结核杆菌抗原融合蛋白及其应用
|
WO1999052708A1
(en)
|
1998-04-13 |
1999-10-21 |
Luminex Corporation |
Liquid labeling with fluorescent microparticles
|
SE9801288D0
(sv)
|
1998-04-14 |
1998-04-14 |
Astra Ab |
Vaccine delivery system and metod of production
|
GB9810236D0
(en)
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
US6406719B1
(en)
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
DK1733735T3
(en)
|
1998-05-22 |
2017-06-19 |
Ottawa Hospital Res Inst |
Methods and products for the induction of mucosal immunity
|
CA2335460A1
(en)
|
1998-06-18 |
1999-12-23 |
Johns Hopkins University School Of Medicine |
Polymers for delivery of nucleic acids
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
US6375952B1
(en)
|
1998-08-07 |
2002-04-23 |
University Of Washington |
Immunological herpes simplex virus antigens and methods for use thereof
|
US6264991B1
(en)
|
1998-08-18 |
2001-07-24 |
Southern Research Institute |
Compositions and methods for treating intracellular infections
|
US6956021B1
(en)
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
US7087236B1
(en)
|
1998-09-01 |
2006-08-08 |
Merrion Research I Limited |
Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof
|
EP2168593A1
(en)
|
1998-09-01 |
2010-03-31 |
Merrion Research III Limited |
Oral vaccine compositions
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
FR2786098B1
(fr)
|
1998-11-20 |
2003-05-30 |
Flamel Tech Sa |
Particules a base de polyaminoacide(s) et susceptibles d'etre utilisees comme vecteurs de principe(s) actif(s), suspension colloidale les comprenant et leurs procedes de fabrication
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
MXPA01005813A
(es)
|
1998-12-08 |
2002-05-06 |
Corixa Corp |
Compuestos y metodos para tratamiento y diagnostico de infeccion por clamidia.
|
US20020119158A1
(en)
|
1998-12-17 |
2002-08-29 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US6579973B1
(en)
|
1998-12-28 |
2003-06-17 |
Corixa Corporation |
Compositions for the treatment and diagnosis of breast cancer and methods for their use
|
WO2000040614A2
(en)
|
1998-12-30 |
2000-07-13 |
Beth Israel Deaconess Medical Center, Inc. |
Characterization of the soc/crac calcium channel protein family
|
US6395714B1
(en)
|
1999-02-24 |
2002-05-28 |
Aventis Pasteur Limited |
Expressing gp140 fragment of primary HIV-1 isolate
|
JP2002543769A
(ja)
|
1999-04-02 |
2002-12-24 |
コリクサ コーポレイション |
肺癌の治療および診断のための化合物および方法
|
US20050158856A1
(en)
*
|
1999-04-20 |
2005-07-21 |
Edelson Richard L. |
Methods for producing functional antigen presenting dendritic cells using biodegradable microparticles for delivery of antigenic materials
|
US6521431B1
(en)
|
1999-06-22 |
2003-02-18 |
Access Pharmaceuticals, Inc. |
Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
JP4210454B2
(ja)
*
|
2001-03-27 |
2009-01-21 |
日本たばこ産業株式会社 |
炎症性腸疾患治療剤
|
US20020009466A1
(en)
*
|
1999-08-31 |
2002-01-24 |
David J. Brayden |
Oral vaccine compositions
|
ATE479441T1
(de)
|
1999-09-03 |
2010-09-15 |
Brigham & Womens Hospital |
Verfahren und zusammensetzungen zur behandlung von entzündungskrankheiten unter verwendung von cadherin-11-modulierenden agenzien
|
US6811783B1
(en)
*
|
1999-09-07 |
2004-11-02 |
Aventis Pasteur Limited |
Immunogenic compositions for protection against chlamydial infection
|
US20050100928A1
(en)
*
|
1999-09-16 |
2005-05-12 |
Zycos Inc., A Delaware Corporation |
Nucleic acids encoding polyepitope polypeptides
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
US20050037086A1
(en)
*
|
1999-11-19 |
2005-02-17 |
Zycos Inc., A Delaware Corporation |
Continuous-flow method for preparing microparticles
|
FR2801226B1
(fr)
|
1999-11-23 |
2002-01-25 |
Flamel Tech Sa |
Suspension colloidale de particules submicroniques de vectorisation de principes actifs et son mode de preparation
|
DK1265915T3
(da)
|
2000-02-23 |
2011-02-14 |
Glaxosmithkline Biolog Sa |
Nye forbindelser
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
US20030060487A1
(en)
*
|
2000-04-12 |
2003-03-27 |
Bamdad R. Shoshana |
Treatment of neurodegenerative disease
|
ES2303525T3
(es)
|
2000-04-21 |
2008-08-16 |
Corixa Corporation |
Compuestos y metodos para el tratamiento y diagnostico de infeccion por chlamydia.
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
ATE299696T1
(de)
|
2000-05-12 |
2005-08-15 |
Pharmacia & Upjohn Co Llc |
Impfstoffzusammensetzung und verfahren zur herstellung derselben sowie verfahren zur impfung von wirbeltieren
|
WO2001093835A1
(en)
*
|
2000-06-02 |
2001-12-13 |
Zycos Inc. |
Delivery systems for bioactive agents
|
FR2814952B1
(fr)
|
2000-10-06 |
2004-01-02 |
Flamel Tech Sa |
Suspension colloidale de particules submicromiques de vectorisation de principes actifs et leur mode de preparation
|
ATE442866T1
(de)
|
2000-06-20 |
2009-10-15 |
Corixa Corp |
Fusionsproteine aus mycobakterium tuberculosis
|
AU7013401A
(en)
|
2000-06-22 |
2002-01-02 |
Univ Iowa Res Found |
Methods for enhancing antibody-induced cell lysis and treating cancer
|
EP1961819A3
(en)
|
2000-06-28 |
2008-11-12 |
Corixa Corporation |
Composition and methods for the therapy and diagnosis of lung cancer
|
US6565888B1
(en)
|
2000-08-23 |
2003-05-20 |
Alkermes Controlled Therapeutics, Inc. |
Methods and compositions for the targeted delivery of biologically active agents
|
US6797704B2
(en)
|
2000-10-06 |
2004-09-28 |
The Johns Hopkins University |
Systemic delivery of compounds through non-invasive bladder administration
|
ATE430558T1
(de)
|
2000-10-27 |
2009-05-15 |
Baxter Healthcare Sa |
Herstellung von mikrokügelchen
|
EP2322929B1
(en)
|
2000-11-27 |
2016-04-06 |
Minerva Biotechnologies Corporation |
diagnostics, drug screening and treatment for cancer
|
DE60134421D1
(de)
*
|
2000-12-08 |
2008-07-24 |
Coley Pharmaceuticals Gmbh |
Cpg-artige nukleinsäuren und verfahren zu ihrer verwendung
|
JP2005504715A
(ja)
|
2000-12-29 |
2005-02-17 |
アドバンスト インハレーション リサーチ,インコーポレイテッド |
持続放出特性を有する吸入用粒子
|
US20030125236A1
(en)
*
|
2000-12-29 |
2003-07-03 |
Advenced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
EP1361892A4
(en)
|
2001-01-17 |
2004-10-13 |
Trubion Pharmaceuticals Inc |
BINDING DOMAIN FUSION PROTEIN Immunoglobulin
|
US7829084B2
(en)
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
US7618939B2
(en)
*
|
2001-02-15 |
2009-11-17 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods to prevent cancer with cupredoxins
|
US7491394B2
(en)
|
2001-02-15 |
2009-02-17 |
The Board Of Trustees Of The University Of Illinois |
Cytotoxic factors for modulating cell death
|
EP1988097A1
(en)
|
2001-05-09 |
2008-11-05 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
AU2002354644C1
(en)
|
2001-07-10 |
2009-04-30 |
Corixa Corporation |
Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres
|
JP2004537401A
(ja)
*
|
2001-08-08 |
2004-12-16 |
ブラウン ユニバーシティ リサーチ ファウンデーション |
疎水性薬物の微粉砕方法
|
ES2307779T3
(es)
*
|
2001-08-16 |
2008-12-01 |
Baxter International Inc. |
Formulaciones de microparticulas a base de propelentes.
|
EP1455593B1
(en)
|
2001-10-06 |
2013-07-24 |
Merial Limited |
Methods and compositions for promoting growth and innate immunity in young animals
|
EP2292273A3
(en)
|
2001-10-10 |
2011-11-23 |
BioGeneriX AG |
Remodeling and glycoconjugation of peptides
|
US20030125292A1
(en)
*
|
2001-11-07 |
2003-07-03 |
Sean Semple |
Mucoscal vaccine and methods for using the same
|
EP1455754A4
(en)
|
2001-11-19 |
2006-01-18 |
Becton Dickinson Co |
PHARMACEUTICAL COMPOSITIONS IN PARTICLE FORM
|
WO2003043603A1
(en)
*
|
2001-11-20 |
2003-05-30 |
Advanced Inhalation Research, Inc. |
Particulate compositions for improving solubility of poorly soluble agents
|
EP1455755B1
(en)
|
2001-11-20 |
2013-04-17 |
Civitas Therapeutics, Inc. |
Improved particulate compositions for pulmonary delivery
|
WO2003049701A2
(en)
*
|
2001-12-10 |
2003-06-19 |
Spherics, Inc. |
Methods and products useful in the formation and isolation of microparticles
|
WO2003049752A2
(en)
|
2001-12-11 |
2003-06-19 |
Institut Pasteur |
Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
|
EP1581119B1
(en)
|
2001-12-17 |
2013-01-30 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
|
MXPA04005865A
(es)
|
2001-12-19 |
2004-09-13 |
Nektar Therapeutics |
Suministro de aminoglucosidos a los pulmones.
|
EP1483283A4
(en)
|
2002-03-13 |
2007-04-11 |
Signum Biosciences Inc |
MODULATION OF PROTEIN METHYLATION AND PHOSPHOPROTEIN PHOSPHATE
|
RU2302865C2
(ru)
|
2002-04-04 |
2007-07-20 |
Коли Фармасьютикал Гмбх |
Иммуностимулирующие g, u-содержащие олигорибонуклеотиды
|
ATE419840T1
(de)
|
2002-04-09 |
2009-01-15 |
Flamel Tech Sa |
Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
|
EP3425059A1
(en)
|
2002-05-09 |
2019-01-09 |
The Brigham and Women's Hospital, Inc. |
1l1rl-1 as a cardiovascular disease marker
|
US20040009944A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Methylated immunostimulatory oligonucleotides and methods of using the same
|
US20040013649A1
(en)
*
|
2002-05-10 |
2004-01-22 |
Inex Pharmaceuticals Corporation |
Cancer vaccines and methods of using the same
|
FR2840614B1
(fr)
|
2002-06-07 |
2004-08-27 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
|
EP1523582B1
(en)
|
2002-07-18 |
2008-11-12 |
University of Washington |
Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same
|
WO2004035028A1
(fr)
*
|
2002-10-17 |
2004-04-29 |
Gosudarstvenny Nauchny Tsentr Virusologii I Biotekhnologii 'vektor' |
Procede de production d'une forme microencapsulee d'un vaccin viral vivant
|
DE60332377D1
(de)
*
|
2002-10-21 |
2010-06-10 |
Eisai Inc |
Zusammensetzungen und verfahren zurbehandlung von krankheiten, die durch das humane papillomavirus vermitteltwerden
|
ZA200503511B
(en)
|
2002-10-29 |
2006-10-25 |
Coley Pharmaceutical Group Ltd |
Use of CPG oligonucleotides in the treatment of hepatitis C virus infection
|
CA2537263C
(en)
|
2002-11-27 |
2017-05-30 |
Minerva Biotechnologies Corporation |
Techniques and compositions for the diagnosis and treatment of cancer (muc1)
|
ES2380147T3
(es)
|
2003-02-11 |
2012-05-09 |
Shire Human Genetic Therapies, Inc. |
Diagnóstico y tratamiento de deficiencia múltiple de sulfatasas y otras usando una enzima generadora de formilglicina(FGE)
|
US20060240024A1
(en)
|
2003-02-28 |
2006-10-26 |
The Johns Hopkins University |
T cell regulation
|
WO2004078943A2
(en)
*
|
2003-03-04 |
2004-09-16 |
California Institute Of Technology |
Alternative heterocycles for dna recognition
|
KR20060003862A
(ko)
|
2003-03-14 |
2006-01-11 |
네오스 테크놀로지스, 인크. |
수용성분기폴리머 및 그 접합체
|
NZ542586A
(en)
|
2003-04-09 |
2009-11-27 |
Biogenerix Ag |
Method of forming a covalent conjugate between a G-CSF peptide and PEG
|
WO2004111199A2
(en)
|
2003-06-12 |
2004-12-23 |
University Of Colorado System Technology |
Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors
|
WO2005014650A2
(en)
|
2003-06-16 |
2005-02-17 |
Celltech R & D, Inc. |
Antibodies specific for sclerostin and methods for increasing bone mineralization
|
DE10329087B4
(de)
|
2003-06-27 |
2014-02-13 |
Biomedical International R + D Gmbh |
Antigenhaltige Mikrosphären zur Allergietherapie
|
US20070092452A1
(en)
*
|
2003-07-18 |
2007-04-26 |
Julia Rashba-Step |
Methods for fabrication, uses, compositions of inhalable spherical particles
|
US20050142205A1
(en)
*
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
RU2426590C2
(ru)
*
|
2003-07-18 |
2011-08-20 |
Бакстер Интернэшнл Инк. |
Способы изготовления, применение и композиции небольших сферических частиц, приготовленных регулируемым фазовым разделением
|
EP1646354A4
(en)
*
|
2003-07-22 |
2010-03-17 |
Baxter Int |
SMALL SPHERICAL PARTICLES OF LOW MOLECULAR WEIGHT MOLECULES AND PROCESSES FOR THEIR PREPARATION AND USE
|
US7663017B2
(en)
|
2003-07-30 |
2010-02-16 |
Institut Pasteur |
Transgenic mice having a human major histocompatability complex (MHC) phenotype, experimental uses and applications
|
CA2535971C
(en)
|
2003-08-20 |
2018-04-10 |
Biosite, Inc. |
Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
|
US20060173171A1
(en)
*
|
2003-08-26 |
2006-08-03 |
Bamdad Cynthia C |
Techniques and compositions for diagnosis and treatment of cancer (muci)
|
EP1675614A2
(en)
*
|
2003-10-11 |
2006-07-05 |
Inex Pharmaceuticals Corp. |
Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity
|
EP1697399B1
(en)
|
2003-12-12 |
2016-11-23 |
GOVERNMENT OF THE UNITED STATES OF AMERICA, as repr. by THE SECR. OF THE DEPT. OF HEALTH AND HUMAN SERVICES AND HIS SUCCESSORS |
A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
|
EP2248895B8
(en)
|
2003-12-19 |
2016-09-21 |
Autotelic LLC |
Combination therapy associating a TGF-beta antagonist with a chemotherapeutic agent
|
US7452730B2
(en)
*
|
2004-01-16 |
2008-11-18 |
California Institute Of Technology |
DNA-binding polymers
|
EP1568383A3
(en)
|
2004-02-27 |
2005-11-16 |
Antisense Pharma GmbH |
Use of an oligonucleotide or its active derivative for the preparation of a pharmaceutical composition for inhibiting the formation of metastases in cancer treatment
|
MXPA06009794A
(es)
*
|
2004-02-27 |
2007-03-15 |
Antisense Pharma Gmbh |
Composicion farmaceutica.
|
US7063151B2
(en)
*
|
2004-03-05 |
2006-06-20 |
Halliburton Energy Services, Inc. |
Methods of preparing and using coated particulates
|
EP2455400B1
(en)
|
2004-04-21 |
2019-03-20 |
The Brigham and Women's Hospital, Inc. |
Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
|
US20050239723A1
(en)
*
|
2004-04-27 |
2005-10-27 |
Amin Avinash N |
Compositions and methods useful for treatment of acne
|
JP5634009B2
(ja)
*
|
2004-05-12 |
2014-12-03 |
バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated |
タンパク質を含み、そして高濃度のタンパク質で注射性能を示すミクロスフェア
|
JP2007537288A
(ja)
|
2004-05-12 |
2007-12-20 |
バクスター インターナショナル インコーポレイテッド |
オリゴヌクレオチド含有マイクロスフェア、1型糖尿病を処置する医薬の製造のための、その使用
|
US8728525B2
(en)
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
DK1765294T3
(da)
|
2004-05-12 |
2008-11-10 |
Baxter Int |
Nukleinsyremikrokugler samt deres fremstilling og afgivelse
|
CA2567597C
(en)
|
2004-05-25 |
2014-03-18 |
Oregon Health And Science University |
Siv and hiv vaccination using rhcmv-and hcmv-based vaccine vectors
|
US20060014285A1
(en)
*
|
2004-07-14 |
2006-01-19 |
Eldridge Gary R |
Methods and compositions for inhibiting biofilms
|
US7604978B2
(en)
|
2004-07-14 |
2009-10-20 |
Sequoia Sciences, Inc. |
Inhibition of biofilm formation
|
US20060264411A1
(en)
*
|
2005-05-20 |
2006-11-23 |
Eldridge Gary R |
Control of biofilm formation
|
DE602005023629D1
(de)
|
2004-07-14 |
2010-10-28 |
Univ California |
Biomarker für den frühzeitigen nachweis von ovarialkarzinom
|
WO2006020060A2
(en)
|
2004-07-15 |
2006-02-23 |
Tetralogic Pharmaceuticals Corporation |
Iap binding compounds
|
BRPI0513959A
(pt)
|
2004-07-30 |
2008-05-20 |
Rinat Neuroscience Corp |
anticorpos dirigidos contra o peptìdeo beta-amilóide, suas composições farmacêuticas, kit e métodos de fabricação dos mesmos
|
US9132116B2
(en)
*
|
2004-08-02 |
2015-09-15 |
Willowcroft Pharm Inc. |
Mast cell stabilizers to prevent or treat laminitis
|
CA2577442A1
(en)
|
2004-08-17 |
2006-03-02 |
The Johns Hopkins University |
Pde5 inhibitor compositions and methods for treating cardiac indications
|
EP2338994B1
(en)
*
|
2004-09-02 |
2014-03-19 |
Yale University |
Regulation of oncogenes by microRNAs
|
WO2007053135A1
(en)
*
|
2004-09-14 |
2007-05-10 |
Minerva Biotechnologies Corporation |
Methods for diagnosis and treatment of cancer
|
EP1797108A1
(en)
|
2004-09-14 |
2007-06-20 |
Gary R. Eldridge |
Compounds, compositions and methods for controlling biofilms and bacterial infections
|
RU2419628C2
(ru)
*
|
2004-09-22 |
2011-05-27 |
ГлаксоСмитКлайн Байолоджикалз с.а. |
Иммуногенная композиция для применения в вакцинации против стафилококков
|
WO2006034454A1
(en)
*
|
2004-09-23 |
2006-03-30 |
The Trustees Of The University Of Princeton |
Bcl-2 family member and bh-3 only proteins for use in development of peptidomimetics
|
ES2439229T3
(es)
|
2004-10-06 |
2014-01-22 |
The Brigham And Women's Hospital, Inc. |
Relevancia de niveles logrados de marcadores de inflamación sistémica tras el tratamiento
|
WO2006042156A2
(en)
|
2004-10-08 |
2006-04-20 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS represneted by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION |
Modulation of replicative fitness by using less frequently used synonymous codons
|
WO2007001448A2
(en)
|
2004-11-04 |
2007-01-04 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
US20060275230A1
(en)
|
2004-12-10 |
2006-12-07 |
Frank Kochinke |
Compositions and methods for treating conditions of the nail unit
|
TW200637618A
(en)
|
2004-12-10 |
2006-11-01 |
Talima Therapeutics Inc |
Compositions and methods for treating conditions of the nail unit
|
US8137907B2
(en)
*
|
2005-01-03 |
2012-03-20 |
Cold Spring Harbor Laboratory |
Orthotopic and genetically tractable non-human animal model for liver cancer and the uses thereof
|
ES2449195T3
(es)
|
2005-01-10 |
2014-03-18 |
Ratiopharm Gmbh |
Factor estimulante de colonias de granulocitos glicopegilado
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
US8221804B2
(en)
|
2005-02-03 |
2012-07-17 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
EP2500031A3
(en)
|
2005-02-24 |
2012-12-26 |
Joslin Diabetes Center, Inc. |
Compositions and Methods for Treating Vascular Permeability
|
KR101317661B1
(ko)
|
2005-02-25 |
2013-10-15 |
테트랄로직 파마슈티칼스 코포레이션 |
이량체성 iap 억제제
|
US7851189B2
(en)
*
|
2005-03-07 |
2010-12-14 |
Boston Scientific Scimed, Inc. |
Microencapsulated compositions for endoluminal tissue engineering
|
EP1701165A1
(en)
|
2005-03-07 |
2006-09-13 |
Johannes Dr. Coy |
Therapeutic and diagnostic uses of TKTL1 and inhibitors and activators thereof
|
ES2720288T3
(es)
|
2005-03-30 |
2019-07-19 |
Minerva Biotechnologies Corp |
Proliferación de células que expresan MUC1
|
CA2610292C
(en)
*
|
2005-03-30 |
2015-06-02 |
Minerva Biotechnologies Corporation |
Proliferation of muc1 expressing cells
|
UA97943C2
(ru)
|
2005-03-31 |
2012-04-10 |
ГлаксоСмитКлайн Байолоджикалз с.а. |
Вакцина против инфекции chlamydia
|
US20060228384A1
(en)
*
|
2005-04-06 |
2006-10-12 |
Sequoia Sciences, Inc. |
Control of biofilm with a biofilm inhibitor
|
US20070154992A1
(en)
|
2005-04-08 |
2007-07-05 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
KR20070122563A
(ko)
|
2005-04-19 |
2007-12-31 |
일라이 릴리 앤드 캄파니 |
질병에의 면역학적 개입을 위한 1가 및 다가 합성 다당류항원
|
EP1877426B1
(en)
|
2005-04-29 |
2012-02-01 |
GlaxoSmithKline Biologicals SA |
Method for preventing or treating m tuberculosis infection
|
UY29504A1
(es)
|
2005-04-29 |
2006-10-31 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
|
US8097597B2
(en)
|
2005-05-05 |
2012-01-17 |
Antisense Pharma Gmbh |
Use of low doses of oligonucleotides antisense to TGF-β genes in the treatment of brain tumors
|
US20080193543A1
(en)
*
|
2005-05-17 |
2008-08-14 |
Brown University Research Foundation |
Drug Delivery Formulations For Targeted Delivery
|
WO2007002528A1
(en)
*
|
2005-06-23 |
2007-01-04 |
Yale University |
Anti-aging micrornas
|
EP1910410B1
(en)
|
2005-07-01 |
2011-10-26 |
Forsyth Dental Infirmary for Children |
Tuberculosis antigen detection assays and vaccines
|
US20070014739A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Eldridge Gary R |
Compositions and methods for controlling biofilms and bacterial infections
|
CN101282994B
(zh)
*
|
2005-07-22 |
2013-09-18 |
Y's治疗有限公司 |
抗cd26抗体及其使用方法
|
NZ564764A
(en)
|
2005-07-25 |
2011-08-26 |
Emergent Product Dev Seattle |
B-cell reduction using CD37-specific and CD20-specific binding molecules
|
CN101600475A
(zh)
|
2005-07-27 |
2009-12-09 |
佛罗里达大学研究基金会有限公司 |
修正蛋白质错误折叠的小型化合物及其使用
|
US20100256046A1
(en)
*
|
2009-04-03 |
2010-10-07 |
Tetralogic Pharmaceuticals Corporation |
Treatment of proliferative disorders
|
JP2009509128A
(ja)
*
|
2005-08-09 |
2009-03-05 |
テトラロジック ファーマシューティカルズ コーポレーション |
増殖性疾患の治療
|
TWI404537B
(zh)
|
2005-08-19 |
2013-08-11 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之8-經取代苯并氮雜呯
|
WO2007027559A2
(en)
|
2005-08-29 |
2007-03-08 |
Shashoua Victor E |
Neuroprotective and neurorestorative methods and compositions
|
US20080021198A1
(en)
*
|
2005-10-12 |
2008-01-24 |
Yigong Shi |
Modulators of protein phosphatase 2A and PP2A methyl esterase
|
US8658608B2
(en)
*
|
2005-11-23 |
2014-02-25 |
Yale University |
Modified triple-helix forming oligonucleotides for targeted mutagenesis
|
EP2883957A1
(en)
|
2005-11-25 |
2015-06-17 |
Zoetis Belgium S.A. |
Immunostimmulatory oligoribonucleotides
|
EP1963364A2
(en)
*
|
2005-12-01 |
2008-09-03 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Compounds and methods for inhibiting apoptosis
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
US8859209B2
(en)
*
|
2006-01-12 |
2014-10-14 |
Carviar Aps |
Reimmunization and antibody design
|
WO2007082105A2
(en)
|
2006-01-16 |
2007-07-19 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chlamydia vaccine
|
US8921050B2
(en)
|
2006-03-17 |
2014-12-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of diagnosing renal cell carcinoma
|
WO2008105773A2
(en)
|
2006-03-31 |
2008-09-04 |
Massachusetts Institute Of Technology |
System for targeted delivery of therapeutic agents
|
JP5524610B2
(ja)
|
2006-04-07 |
2014-06-18 |
ザ リサーチ ファウンデーション オブ ステイト ユニバーシティー オブ ニューヨーク |
トランスコバラミン受容体ポリペプチド、核酸およびその調節因子、ならびに細胞の増殖の調節ならびにガンおよびコバラミン欠損症の処置に使用する関連方法
|
WO2007124755A1
(en)
|
2006-05-02 |
2007-11-08 |
The Antibody Project Aps |
Method for immunizing an avian species
|
US10522240B2
(en)
|
2006-05-03 |
2019-12-31 |
Population Bio, Inc. |
Evaluating genetic disorders
|
US7702468B2
(en)
|
2006-05-03 |
2010-04-20 |
Population Diagnostics, Inc. |
Evaluating genetic disorders
|
NZ612319A
(en)
|
2006-06-12 |
2015-04-24 |
Emergent Product Dev Seattle |
Single-chain multivalent binding proteins with effector function
|
US20100129403A1
(en)
|
2006-06-20 |
2010-05-27 |
Transgene S.A. |
Recombinant viral vaccine
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
WO2008014240A2
(en)
|
2006-07-24 |
2008-01-31 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
US20100056495A1
(en)
*
|
2006-07-24 |
2010-03-04 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
WO2008014238A2
(en)
*
|
2006-07-24 |
2008-01-31 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
AU2007276760B2
(en)
|
2006-07-24 |
2012-01-19 |
Tetralogic Pharmaceuticals Corporation |
Dimeric IAP antagonists
|
CL2007002166A1
(es)
*
|
2006-07-24 |
2008-01-25 |
Tetralogic Pharm Corp |
Compuestos derivados de heterociclos de nitrogeno, antagonistas de los inhibidores de las proteinas de la apoptosis; sus composiciones farmaceuticas; y uso de dichos compuestos para el tratamiento del cancer.
|
CA2657517C
(en)
|
2006-08-04 |
2016-11-01 |
Baxter International Inc. |
Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
|
US20080153773A1
(en)
*
|
2006-08-08 |
2008-06-26 |
Yigong Shi |
Modulators of phosphotyrosyl phosphatase activator
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
US8273361B2
(en)
|
2006-09-26 |
2012-09-25 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
WO2008147426A2
(en)
*
|
2006-10-04 |
2008-12-04 |
The Brigham And Women's Hospital, Inc. |
Methods and compositions for immunomodulation
|
PT2068907T
(pt)
|
2006-10-04 |
2018-01-15 |
Novo Nordisk As |
Açúcares e glicopéptidos peguilados ligados a glicerol
|
US20100092480A1
(en)
*
|
2006-10-13 |
2010-04-15 |
The Trustees Of The University Of Princeton |
Modulators of protein phosphatase 2a
|
RU2373957C2
(ru)
|
2006-10-13 |
2009-11-27 |
Александр Метталинович Тишин |
Носитель для лекарственных средств и биологически активных веществ для лечения и диагностики и применение его для создания лекарственных средств и способа регулируемой управляемой доставки лекарственного средства или биологически активного вещества с регулируемой десорбцией его
|
US7645616B2
(en)
*
|
2006-10-20 |
2010-01-12 |
The University Of Hong Kong |
Use of lipocalin-2 as a diagnostic marker and therapeutic target
|
US8202967B2
(en)
|
2006-10-27 |
2012-06-19 |
Boehringer Ingelheim Vetmedica, Inc. |
H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
|
WO2008098165A2
(en)
|
2007-02-09 |
2008-08-14 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
WO2008109773A2
(en)
*
|
2007-03-06 |
2008-09-12 |
Cornell Research Foundation, Inc. |
Chronic obstructive pulmonary disease susceptibility and related compositions and methods
|
WO2008116216A1
(en)
*
|
2007-03-22 |
2008-09-25 |
Medical College Of Georgia Research Institute, Inc. |
Compositions and methods for inhibiting cancer metastasis
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
WO2008122039A2
(en)
*
|
2007-04-02 |
2008-10-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selenocysteine mediated hybrid antibody molecules
|
EP2144600A4
(en)
|
2007-04-04 |
2011-03-16 |
Massachusetts Inst Technology |
POLY (AMINIC ACID) TARGET MOLECULES
|
US7928202B2
(en)
|
2007-04-12 |
2011-04-19 |
The Brigham And Women's Hospital, Inc. |
Targeting ABCB5 for cancer therapy
|
AU2008242842B2
(en)
|
2007-04-17 |
2014-06-05 |
Baxter Healthcare Sa |
Nucleic acid microparticles for pulmonary delivery
|
WO2008130619A2
(en)
*
|
2007-04-20 |
2008-10-30 |
Trustees Of Boston College |
A composition comprising an inhibitor of pde4 and/or pde7
|
EP2152304B1
(en)
|
2007-05-02 |
2018-08-22 |
The Regents of the University of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
BRPI0811621A2
(pt)
*
|
2007-05-17 |
2014-10-21 |
Coley Pharm Group Inc |
Oligonucleotídeos de classe a com potência imunoestimuladora, composição contendo os mesmos e uso da referida composição
|
EP2166844A4
(en)
*
|
2007-06-07 |
2013-09-04 |
Evonik Corp |
DOSAGE FORMS WITH EXTENDED ACTION AND REDUCED MASS
|
EP2152900B1
(en)
|
2007-06-08 |
2014-10-15 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Methods for determining hepatocellular carcinoma subtype
|
WO2009022215A1
(en)
|
2007-08-13 |
2009-02-19 |
Pfizer Inc. |
Combination motif immune stimulatory oligonucleotides with improved activity
|
US8932558B2
(en)
*
|
2007-10-05 |
2015-01-13 |
Plaxgen Inc |
Multi-subunit biological complexes for treatment of plaque-associated diseases
|
MX2010003642A
(es)
|
2007-10-12 |
2010-08-09 |
Massachusetts Inst Technology |
Nanotecnologia de vacuna.
|
US8619257B2
(en)
|
2007-12-13 |
2013-12-31 |
Kimberley-Clark Worldwide, Inc. |
Recombinant bacteriophage for detection of nosocomial infection
|
US20090274682A1
(en)
*
|
2008-02-05 |
2009-11-05 |
The Trustees Of Princeton University |
Demethylation and inactivation of protein phosphatase 2a
|
WO2009108745A1
(en)
*
|
2008-02-26 |
2009-09-03 |
The Trustees Of Princeton University |
Structure of a protein phosphatase 2a holoenzyme: insights into tau dephosphorylation
|
EP2257626A2
(en)
*
|
2008-03-01 |
2010-12-08 |
Abraxis BioScience, LLC |
Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas
|
WO2009126306A2
(en)
|
2008-04-10 |
2009-10-15 |
Cell Signaling Technology, Inc. |
Compositions and methods for detecting egfr mutations in cancer
|
EP2385370A1
(en)
|
2008-04-10 |
2011-11-09 |
Massachusetts Institute of Technology (MIT) |
Methods for identification and use of agents targeting cancer stem cells
|
EP2365003A1
(en)
|
2008-04-11 |
2011-09-14 |
Emergent Product Development Seattle, LLC |
CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
|
US20100227853A1
(en)
*
|
2008-04-18 |
2010-09-09 |
Trustees Of Boston College |
Inhibitors of cyclic amp phosphodiesterases
|
EP2281042B1
(en)
|
2008-04-18 |
2015-08-26 |
Baxter International Inc. |
Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
|
WO2009130616A2
(en)
|
2008-04-25 |
2009-10-29 |
Innate Pharma |
Improved tlr3 agonist compositions
|
CA2723716A1
(en)
*
|
2008-05-07 |
2009-11-12 |
Abraxis Bioscience, Llc |
Enhancement of drug therapy by mirna
|
EP2123748A1
(en)
|
2008-05-20 |
2009-11-25 |
Institut Pasteur |
2'-5'-oligoadenylate synthetase 3 for preventing and treating positive-sense single-stranded rna virus infection
|
WO2009151561A2
(en)
|
2008-06-12 |
2009-12-17 |
President And Fellows Of Harvard College |
Methods and compounds for antimicrobial intervention
|
DK2318832T3
(da)
|
2008-07-15 |
2014-01-20 |
Academia Sinica |
Glycan-arrays på PTFE-lignende aluminiumcoatede objektglas og relaterede fremgangsmåder
|
EP2323679A4
(en)
|
2008-07-25 |
2012-08-22 |
Univ Colorado |
CLIP INHIBITORS AND METHODS FOR MODULATING IMMUNE FUNCTION
|
US9273136B2
(en)
*
|
2008-08-04 |
2016-03-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Fully human anti-human NKG2D monoclonal antibodies
|
US8367427B2
(en)
|
2008-08-20 |
2013-02-05 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US8323615B2
(en)
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing multi-phasic dispersions
|
US8323685B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
EP2328412A4
(en)
|
2008-09-17 |
2012-03-14 |
Tetralogic Pharm Corp |
IPA INHIBITORS
|
US8729053B2
(en)
*
|
2008-09-22 |
2014-05-20 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Nuclear factor kappa B pathway inhibitor composition and use of same
|
WO2010042759A2
(en)
|
2008-10-08 |
2010-04-15 |
Kyphia Pharmaceuticals Inc |
Gaba conjugates and methods of use thereof
|
CN102272290B
(zh)
|
2008-10-09 |
2018-08-14 |
米纳瓦生物技术公司 |
用于在细胞中诱导多能性的方法
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
DK3130923T3
(da)
|
2008-11-14 |
2020-05-11 |
Brigham & Womens Hospital Inc |
Terapeutiske fremgangsmåder i forbindelse med cancerstamceller
|
EP2376089B1
(en)
|
2008-11-17 |
2018-03-14 |
The Regents of the University of Michigan |
Cancer vaccine compositions and methods of using the same
|
WO2010075417A1
(en)
|
2008-12-23 |
2010-07-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Survivin specific t cell receptor for treating cancer
|
WO2010075303A1
(en)
|
2008-12-23 |
2010-07-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Splicing factors with a puf protein rna-binding domain and a splicing effector domain and uses of same
|
US8309356B2
(en)
*
|
2009-04-01 |
2012-11-13 |
Yale University |
Pseudocomplementary oligonucleotides for targeted gene therapy
|
ES2713349T3
(es)
|
2009-04-15 |
2019-05-21 |
Bmg Pharma S P A |
Composiciones de sal mineral-ácido sulfónico y procedimientos de uso
|
EP2421899B1
(en)
|
2009-04-23 |
2016-06-08 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Anti-human ror1 antibodies
|
WO2010127235A1
(en)
|
2009-04-30 |
2010-11-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Schweinfurthins and uses thereof
|
AU2010246652B2
(en)
|
2009-05-14 |
2014-10-02 |
Elanco Animal Health Gmbh |
Enhanced immune response in avian species
|
WO2010132532A1
(en)
|
2009-05-15 |
2010-11-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
B cell surface reactive antibodies
|
EP2437753B1
(en)
|
2009-06-05 |
2016-08-31 |
Infectious Disease Research Institute |
Synthetic glucopyranosyl lipid adjuvants and vaccine compositions containing them
|
US20110038852A1
(en)
*
|
2009-06-10 |
2011-02-17 |
3-V Biosciences, Inc. |
Antivirals that target transporters, carriers, and ion channels
|
WO2010148111A1
(en)
|
2009-06-16 |
2010-12-23 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
IN2012DN00352A
(h)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
US8283372B2
(en)
|
2009-07-02 |
2012-10-09 |
Tetralogic Pharmaceuticals Corp. |
2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
|
WO2011011092A1
(en)
|
2009-07-22 |
2011-01-27 |
University Of Massachusetts |
Methods and compositions to reduce oxidative stress
|
CN102712924A
(zh)
|
2009-07-30 |
2012-10-03 |
安提森斯制药有限公司 |
化疗药剂和TGF-β系统抑制剂的组合
|
EP2292260A1
(en)
|
2009-08-13 |
2011-03-09 |
Institut Pasteur |
Use of mycobacterium bovis BCG killed by extended freeze drying (EFD) for preventing or treating atherosclerosis
|
EP2287304A1
(en)
|
2009-08-17 |
2011-02-23 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Novel treatment of patients after stent implantation or balloon dilatation and novel drug eluting stents
|
HUE031797T2
(en)
|
2009-08-18 |
2017-08-28 |
Ventirx Pharmaceuticals Inc |
Substituted benzoazepines as Toll-like receptor modulators
|
PT2467377T
(pt)
|
2009-08-18 |
2017-04-04 |
Array Biopharma Inc |
Benzoazepinas substituídas como moduladores de recetores de tipo toll
|
WO2011034950A1
(en)
|
2009-09-16 |
2011-03-24 |
Vaxart, Inc. |
Immunization strategy to prevent h1n1 infection
|
US8465743B2
(en)
|
2009-10-01 |
2013-06-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
|
US20110104138A1
(en)
|
2009-11-03 |
2011-05-05 |
Institut Pasteur |
Use of the innate immunity gene oasl for preventing or treating infection with negative strand rna viruses
|
WO2011061625A2
(en)
|
2009-11-19 |
2011-05-26 |
Solis Biodyne |
Compositions for increasing polypeptide stability and activity, and related methods
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
BR112012017473A2
(pt)
|
2010-01-13 |
2019-09-24 |
Institut National De La Sante Et De La Rech Medicale Inserm Epst |
pirido(1,2-a) pirimidinas, seu uso, bem como composição farmacêutica compreendendo tais compostos
|
UA110103C2
(uk)
|
2010-01-27 |
2015-11-25 |
Ґлаксосмітклайн Байолоджікалз С.А. |
Модифікований туберкульозний антиген
|
US9556248B2
(en)
|
2010-03-19 |
2017-01-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hepatocyte growth factor fragments that function as potent met receptor agonists and antagonists
|
US10338069B2
(en)
|
2010-04-12 |
2019-07-02 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
WO2011133802A1
(en)
|
2010-04-21 |
2011-10-27 |
Helix Therapeutics, Inc. |
Compositions and methods for treatment of lysosomal storage disorders
|
WO2011133803A1
(en)
|
2010-04-21 |
2011-10-27 |
Helix Therapeutics, Inc. |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
CA2805267C
(en)
|
2010-05-04 |
2019-07-30 |
The Brigham And Women's Hospital, Inc. |
Detection and treatment of fibrosis
|
WO2011138032A2
(en)
|
2010-05-05 |
2011-11-10 |
Artemev, Timur |
Universal influenza vaccines and methods for their generation
|
US8658603B2
(en)
|
2010-06-16 |
2014-02-25 |
The Regents Of The University Of Michigan |
Compositions and methods for inducing an immune response
|
WO2012012627A1
(en)
|
2010-07-22 |
2012-01-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method of preventing or treating viral infection
|
US8862410B2
(en)
|
2010-08-02 |
2014-10-14 |
Population Diagnostics, Inc. |
Compositions and methods for discovery of causative mutations in genetic disorders
|
AR083533A1
(es)
|
2010-10-22 |
2013-03-06 |
Boehringer Ingelheim Vetmed |
Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
|
CN108744262A
(zh)
|
2010-11-23 |
2018-11-06 |
普莱萨格生命科学公司 |
用于实体递送的治疗方法和组合物
|
CA2818992C
(en)
|
2010-12-01 |
2021-05-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric rabbit/human ror1 antibodies
|
HRP20190779T1
(hr)
|
2010-12-22 |
2019-06-28 |
Bayer Intellectual Property Gmbh |
Pojačani imunosni odgovor kod goveda
|
BR112013017947A2
(pt)
|
2011-01-12 |
2018-12-18 |
Array Biopharma Inc |
benzoazepinas substituídas como moduladores de receptor toll-like
|
AU2012205486B2
(en)
|
2011-01-12 |
2017-02-02 |
Array Biopharma, Inc. |
Substituted benzoazepines as toll-like receptor modulators
|
CN103459598B
(zh)
|
2011-02-03 |
2016-08-10 |
米尔纳医疗股份有限公司 |
Mir-124的合成模拟物
|
US8586727B2
(en)
|
2011-02-03 |
2013-11-19 |
Mirna Therapeutics, Inc. |
Synthetic mimics of miR-34
|
HRP20170500T1
(hr)
|
2011-03-08 |
2017-06-02 |
3-V Biosciences, Inc. |
Heterociklički modulatori sinteze lipida
|
KR101938343B1
(ko)
|
2011-03-09 |
2019-01-14 |
셀 시그널링 테크놀러지, 인크. |
모노클로날 항체를 생성하는 방법 및 시약
|
EP2686418A4
(en)
|
2011-03-17 |
2015-04-22 |
Minerva Biotechnologies Corp |
PROCESS FOR OBTAINING PLURIPOTENT STEM CELLS
|
MX350795B
(es)
|
2011-04-08 |
2017-09-19 |
Inmune Design Corp |
Composiciones inmunogenicas y metodos para utilizar las composiciones para inducir respuestas inmunes humorales y celulares.
|
PL2694549T3
(pl)
|
2011-04-08 |
2019-01-31 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeryczne receptory antygenowe anty-wariant III receptora czynnika wzrostu naskórka i ich zastosowanie do leczenia raka
|
WO2012145739A1
(en)
|
2011-04-21 |
2012-10-26 |
Trustees Of Tufts College |
Compositions and methods for stabilization of active agents
|
WO2012167053A1
(en)
|
2011-06-01 |
2012-12-06 |
Janus Biotherapeutics, Inc. |
Novel immune system modulators
|
EP2713736B1
(en)
|
2011-06-01 |
2023-08-02 |
Janus Biotherapeutics, Inc. |
Novel immune system modulators
|
CN103917093B
(zh)
|
2011-06-14 |
2017-08-11 |
比卡姆药品公司 |
视蛋白结合配体、组合物及使用方法
|
WO2012174455A2
(en)
|
2011-06-17 |
2012-12-20 |
University Of Tennessee Research Foundation |
Group a streptococcus multivalent vaccine
|
WO2012177595A1
(en)
|
2011-06-21 |
2012-12-27 |
Oncofactor Corporation |
Compositions and methods for the therapy and diagnosis of cancer
|
CA3149018A1
(en)
|
2011-07-18 |
2013-01-24 |
President And Fellows Of Harvard College |
Engineered microbe-targeting molecules and uses thereof
|
WO2013013061A1
(en)
|
2011-07-19 |
2013-01-24 |
University Of Vermont And State Agricultural College |
Methods and compounds for treating cancer
|
US8324264B1
(en)
|
2011-07-22 |
2012-12-04 |
Sequoia Sciences, Inc. |
Inhibitors of bacterial biofilms and related methods
|
CA2844197A1
(en)
|
2011-08-03 |
2013-02-07 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolina Healthcare System |
Treatment of fibrosis using microrna-19b
|
AR088028A1
(es)
|
2011-08-15 |
2014-05-07 |
Boehringer Ingelheim Vetmed |
Proteinas h5, de h5n1 para un uso medicinal
|
EP2763677B1
(en)
|
2011-10-04 |
2020-02-26 |
Janus Biotherapeutics, Inc. |
Novel imidazole quinoline-based immune system modulators
|
CA2851388C
(en)
|
2011-10-10 |
2023-11-21 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
JP6466170B2
(ja)
|
2011-10-17 |
2019-02-06 |
ミネルバ バイオテクノロジーズ コーポレーション |
幹細胞の増殖及び誘導用の培地
|
JP6267644B2
(ja)
|
2011-10-20 |
2018-01-24 |
アメリカ合衆国 |
抗cd22キメラ抗原受容体
|
SG11201401851UA
(en)
|
2011-10-28 |
2014-05-29 |
Presage Biosciences Inc |
Methods for drug delivery
|
DK2773779T3
(da)
|
2011-11-04 |
2020-11-23 |
Population Bio Inc |
Fremgangsmåder og sammensætninger til diagnosticering, prognose og forebyggelse af neurologiske tilstande
|
BR112014011417B1
(pt)
|
2011-11-11 |
2021-10-13 |
Fred Hutchinson Cancer Research Center |
Polipeptídeo isolado capaz de elicitar uma resposta de célula t antígeno-específica para ciclina a1 humana, composição imunogênica compreendendo o referido polipeptídeo, bem como método para preparar células apresentadoras de antígeno, antígeno-pulsadas,e uso destas para superexpressão de ccna1
|
US9173884B2
(en)
|
2011-11-30 |
2015-11-03 |
Trustees Of Boston College |
Inhibitors of phosphodiesterase 11 (PDE11)
|
AU2012346214B2
(en)
|
2011-11-30 |
2017-09-14 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
HRP20190960T1
(hr)
|
2012-02-07 |
2019-07-26 |
Infectious Disease Research Institute |
Poboljšane adjuvantne formulacije koje sadrže agoniste tlr4 i postupci njihove upotrebe
|
EP2812452B1
(en)
|
2012-02-09 |
2020-05-27 |
Population Bio, Inc. |
Methods and compositions for screening and treating developmental disorders
|
CN103251941A
(zh)
*
|
2012-02-16 |
2013-08-21 |
海南大学 |
动物病毒性疫苗脉冲释放系统、其制备方法及用途
|
WO2013130773A2
(en)
|
2012-02-29 |
2013-09-06 |
Ethicon Endo-Surgery, Inc. |
Compositions of microbiota and methods related thereto
|
WO2013134577A2
(en)
|
2012-03-08 |
2013-09-12 |
Detectogen, Inc. |
Leishmaniasis antigen detection assays and vaccines
|
CA2868121C
(en)
|
2012-03-23 |
2021-06-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-mesothelin chimeric antigen receptors
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
CN110511278B
(zh)
|
2012-05-07 |
2024-08-09 |
达特茅斯大学理事会 |
抗b7-h6抗体、融合蛋白及其使用方法
|
BR112014028476A2
(pt)
|
2012-05-16 |
2017-08-01 |
Immune Design Corp |
fragmento imunogênico de um polipeptídeo, polinucleotídeo isolado, composição farmacêutica imunogênica, métodos para tratar uma infecção, para gerar uma resposta imune em um sujeito, e para imunizar um sujeito
|
CN104582715A
(zh)
|
2012-07-11 |
2015-04-29 |
佛蒙特大学及州农业学院 |
用于代谢调节的方法和组合物
|
KR101835401B1
(ko)
|
2012-07-13 |
2018-03-08 |
신 니뽄 바이오메디칼 라보라토리즈, 엘티디. |
키랄 핵산 어쥬번트
|
JP6302909B2
(ja)
|
2012-08-18 |
2018-03-28 |
アカデミア シニカAcademia Sinica |
シアリダーゼの同定および画像化のための細胞透過性プローブ
|
EP2887942A4
(en)
|
2012-08-21 |
2016-08-31 |
Genesys Res Inst |
COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ANTHRACYCLIN-INDUCED CARDIOTOXICITY
|
DK2895621T3
(da)
|
2012-09-14 |
2020-11-30 |
Population Bio Inc |
Fremgangsmåder og sammensætning til diagnosticering, prognose og behandling af neurologiske tilstande
|
WO2014052855A1
(en)
|
2012-09-27 |
2014-04-03 |
Population Diagnostics, Inc. |
Methods and compositions for screening and treating developmental disorders
|
US9228184B2
(en)
|
2012-09-29 |
2016-01-05 |
Dynavax Technologies Corporation |
Human toll-like receptor inhibitors and methods of use thereof
|
EP3795694A3
(en)
|
2012-10-02 |
2021-06-23 |
The General Hospital Corporation d/b/a Massachusetts General Hospital |
Methods relating to dna-sensing pathway related conditions
|
CN104822705B
(zh)
|
2012-10-24 |
2019-07-12 |
美国卫生和人力服务部 |
M971嵌合抗原受体
|
WO2014074805A1
(en)
|
2012-11-08 |
2014-05-15 |
Whitehead Institute For Biomedical Research |
Selective targeting of cancer stem cells
|
EP2931272A1
(en)
|
2012-12-12 |
2015-10-21 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Healthcare System |
Methods of treating hepatic fibrosis and associated diseases by regulating rev-erb activity
|
EP2931273A1
(en)
|
2012-12-12 |
2015-10-21 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Healthcare System |
Methods of treating portal hypertension
|
WO2014127825A1
(en)
|
2013-02-21 |
2014-08-28 |
Boehringer Ingelheim Vetmedica Gmbh |
H5 proteins of h5n1 influenza virus for use as a medicament
|
ES2872403T3
(es)
|
2013-03-14 |
2021-11-02 |
Childrens Medical Center |
Péptido Psap para el tratamiento de cánceres que expresan CD36
|
AU2014241396A1
(en)
|
2013-03-14 |
2015-09-17 |
Hallux, Inc. |
Method of treating infections, diseases or disorders of nail unit
|
KR102457668B1
(ko)
|
2013-03-15 |
2022-10-21 |
트러스티즈 오브 터프츠 칼리지 |
저분자량 실크 조성물 및 안정화 실크 조성물
|
US11376329B2
(en)
|
2013-03-15 |
2022-07-05 |
Trustees Of Tufts College |
Low molecular weight silk compositions and stabilizing silk compositions
|
US9790282B2
(en)
|
2013-03-25 |
2017-10-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-CD276 polypeptides, proteins, and chimeric antigen receptors
|
WO2014162007A2
(en)
|
2013-04-04 |
2014-10-09 |
Ieo - Istituto Europeo Di Oncologia Srl |
Thymic stromal lymphopoietin fragments and uses thereof
|
HK1214510A1
(zh)
|
2013-04-18 |
2016-07-29 |
Immune Design Corp. |
用於癌症治疗的gla单一疗法
|
US10274503B2
(en)
|
2013-05-08 |
2019-04-30 |
Vegenics Pty Limited |
Methods of using VEGF-C biomarkers for age-related macular degeneration (AMD) diagnosis
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
AU2014301958B2
(en)
|
2013-06-25 |
2017-11-16 |
The Walter And Eliza Hall Institute Of Medical Research |
Method of treating intracellular infection
|
EP3013365B1
(en)
|
2013-06-26 |
2019-06-05 |
Academia Sinica |
Rm2 antigens and use thereof
|
US10231993B2
(en)
|
2013-06-27 |
2019-03-19 |
University Of Washington Through Its Center For Commercialization |
Biocompatible polymeric system for targeted treatment of thrombotic and hemostatic disorders
|
WO2014210564A1
(en)
|
2013-06-27 |
2014-12-31 |
Academia Sinica |
Glycan conjugates and use thereof
|
WO2015006543A1
(en)
|
2013-07-10 |
2015-01-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method for predicting and detecting tumor metastasis in kidney cancer
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
WO2015013214A2
(en)
|
2013-07-21 |
2015-01-29 |
Whole Biome, Inc. |
Methods and systems for microbiome characterization, monitoring and treatment
|
US9782476B2
(en)
|
2013-09-06 |
2017-10-10 |
Academia Sinica |
Human iNKT cell activation using glycolipids with altered glycosyl groups
|
JP6621752B2
(ja)
|
2013-10-21 |
2019-12-18 |
ソーク インスティテュート フォー バイオロジカル スタディーズ |
変異した線維芽細胞増殖因子(fgf)1および使用方法
|
US10208102B2
(en)
|
2013-11-01 |
2019-02-19 |
University Of Oslo |
Albumin variants and uses thereof
|
WO2015071763A2
(en)
|
2013-11-15 |
2015-05-21 |
Oslo Universitetssykehus Hf |
Ctl peptide epitopes and antigen-specific t cells, methods for their discovery, and uses thereof
|
JP6943568B2
(ja)
|
2013-12-06 |
2021-10-06 |
アメリカ合衆国 |
胸腺間質性リンパ球新生因子受容体特異的キメラ抗原受容体及びそれを使用する方法
|
WO2015095604A2
(en)
|
2013-12-18 |
2015-06-25 |
President And Fellows Of Harvard College |
Methods and assays relating to circulating tumor cells
|
US10226449B2
(en)
|
2013-12-20 |
2019-03-12 |
3-V Biosciences, Inc. |
Heterocyclic modulators of lipid synthesis and combinations thereof
|
BR112016015879B1
(pt)
|
2014-01-07 |
2022-06-14 |
Sagimet Biosciences Inc |
Composto modulador heterocíclico de síntese de lipídeos, composição farmacêutica que compreende dito composto e uso do mesmo para o tratamento de câncer
|
WO2015108046A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤
|
EP3095459A4
(en)
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having antitumor effect and antitumor agent
|
WO2015108047A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
KR20160104727A
(ko)
|
2014-01-16 |
2016-09-05 |
아카데미아 시니카 |
암의 치료 및 검출을 위한 조성물 및 방법
|
EP3096764A1
(en)
|
2014-01-21 |
2016-11-30 |
Immune Design Corp. |
Compositions for use in the treatment of allergic conditions
|
EP3107568B1
(en)
|
2014-02-20 |
2024-03-27 |
Vaxart, Inc. |
Formulations for small intestinal delivery
|
KR20160122849A
(ko)
|
2014-02-28 |
2016-10-24 |
바이엘 애니멀 헬스 게엠베하 |
면역자극성 플라스미드
|
JP6737714B2
(ja)
|
2014-03-14 |
2020-08-12 |
ユニヴァーシティ オブ ワシントン |
ゲノムインスレーターエレメントおよびその使用
|
US10646541B2
(en)
|
2014-03-26 |
2020-05-12 |
Children's Medical Center Corporation |
Cyclic prosaposin peptides and uses thereof
|
CN106415244B
(zh)
|
2014-03-27 |
2020-04-24 |
中央研究院 |
反应性标记化合物及其用途
|
US10293035B2
(en)
|
2014-03-28 |
2019-05-21 |
University Of Washington Through Its Center For Commercialization |
Breast and ovarian cancer vaccines
|
WO2015168255A1
(en)
|
2014-04-29 |
2015-11-05 |
Whitehead Institute For Biomedical Research |
Methods and compositions for targeting cancer stem cells
|
PL3139909T3
(pl)
|
2014-05-09 |
2025-04-14 |
Yale University |
Hiperrozgałęzione cząstki powlekane poliglicerolem
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
DK3149045T3
(da)
|
2014-05-27 |
2023-03-06 |
Academia Sinica |
Sammensætninger og fremgangsmåder vedrørende universelle glycoformer til forbedret antistofeffekt
|
EP4116329A1
(en)
|
2014-05-27 |
2023-01-11 |
Academia Sinica |
Anti-her2 glycoantibodies and uses thereof
|
AU2015267047A1
(en)
|
2014-05-27 |
2017-01-05 |
Academia Sinica |
Anti-CD20 glycoantibodies and uses thereof
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
AU2015267044A1
(en)
|
2014-05-28 |
2016-12-15 |
Academia Sinica |
Anti-TNF-alpha glycoantibodies and uses thereof
|
US10759836B2
(en)
|
2014-07-18 |
2020-09-01 |
University Of Washington |
Cancer vaccine compositions and methods of use thereof
|
EP3398948A3
(en)
|
2014-08-22 |
2018-12-05 |
Janus Biotherapeutics, Inc. |
2,4,6,7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
|
WO2016036403A1
(en)
|
2014-09-05 |
2016-03-10 |
Population Diagnostics Inc. |
Methods and compositions for inhibiting and treating neurological conditions
|
AU2015315294B2
(en)
|
2014-09-08 |
2020-09-17 |
Academia Sinica |
Human iNKT cell activation using glycolipids
|
WO2016044383A1
(en)
|
2014-09-17 |
2016-03-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-cd276 antibodies (b7h3)
|
WO2016054240A1
(en)
|
2014-09-30 |
2016-04-07 |
Sean Dalziel |
Fixed dose combinations for the treatment of viral diseases
|
WO2016057921A1
(en)
|
2014-10-10 |
2016-04-14 |
Baker Jr James R |
Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
|
EP3207150B1
(en)
|
2014-10-14 |
2021-04-28 |
Research Development Foundation |
Methods for generating engineered enzymes
|
CN113730442A
(zh)
|
2014-10-31 |
2021-12-03 |
潘德勒姆治疗公司 |
与病症的微生物治疗和诊断有关的方法和组合物
|
WO2016079527A1
(en)
|
2014-11-19 |
2016-05-26 |
Tetralogic Birinapant Uk Ltd |
Combination therapy
|
WO2016097773A1
(en)
|
2014-12-19 |
2016-06-23 |
Children's Cancer Institute |
Therapeutic iap antagonists for treating proliferative disorders
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
EP3248005B1
(en)
|
2015-01-24 |
2020-12-09 |
Academia Sinica |
Novel glycan conjugates and methods of use thereof
|
CN116199790A
(zh)
|
2015-02-10 |
2023-06-02 |
米纳瓦生物技术公司 |
人源化抗MUCl*抗体
|
AU2016220024B2
(en)
|
2015-02-18 |
2020-10-15 |
University Of Vermont And State Agricultural College |
MCJ agonists and uses therefor
|
WO2016141320A2
(en)
|
2015-03-05 |
2016-09-09 |
Northwestern University |
Non-neuroinvasive viruses and uses thereof
|
KR20170129151A
(ko)
|
2015-03-19 |
2017-11-24 |
3-브이 바이오사이언시스, 인코포레이티드 |
지질 합성의 복소환식 조절제
|
WO2016154585A1
(en)
|
2015-03-26 |
2016-09-29 |
Charles Sentman |
Anti-mica antigen binding fragments, fusion molecules, cells which express and methods of using
|
US10718022B2
(en)
|
2015-04-15 |
2020-07-21 |
University Of Massachusetts |
Compositions and methods for XI chromosome reactivation
|
AU2016256367A1
(en)
|
2015-04-25 |
2017-12-07 |
The General Hospital Corporation |
Anti-fugetactic agent and anti-cancer agent combination therapy and compositions for the treatment of cancer
|
WO2016197018A1
(en)
|
2015-06-05 |
2016-12-08 |
Ibio, Inc. |
Endostatin fragments and variants for use in treating fibrosis
|
KR102773575B1
(ko)
|
2015-06-12 |
2025-02-27 |
박사르트, 인크. |
Rsv 및 노로바이러스 항원들의 소장 내의 전달을 위한 제형들
|
EP3831844B1
(en)
|
2015-06-26 |
2024-03-13 |
Prindex S.r.l. |
Diagnosis and therapy of multiple sclerosis
|
US10655126B2
(en)
|
2015-07-10 |
2020-05-19 |
University Of Vermont And State Agricultural College |
Methods and compositions to treat drug-induced diseases and conditions
|
TW201718001A
(zh)
|
2015-07-31 |
2017-06-01 |
拜耳動物保健有限公司 |
豬物種中增強之免疫反應
|
CN108289928B
(zh)
|
2015-08-06 |
2024-09-17 |
哈佛大学校长及研究员协会 |
改进的微生物-结合分子和其用途
|
ES2876930T3
(es)
|
2015-08-20 |
2021-11-15 |
Asociacion Centro De Investig Cooperativa En Biociencias Cic Biogune |
Métodos y composiciones para tratar enfermedades y afecciones hepáticas
|
EP3349749B1
(en)
|
2015-09-17 |
2022-12-14 |
University of Massachusetts |
Compositions and methods for modulating fmr1 expression
|
JP2018531229A
(ja)
|
2015-09-18 |
2018-10-25 |
ザ ジェネラル ホスピタル コーポレーション ドゥーイング ビジネス アズ マサチューセッツ ジェネラル ホスピタル |
癌の治療のための抗fugetactic剤の局所的送達
|
KR102784293B1
(ko)
|
2015-09-21 |
2025-03-20 |
압테보 리서치 앤드 디벨롭먼트 엘엘씨 |
Cd3 결합 폴리펩타이드
|
SG11201804648RA
(en)
|
2015-12-04 |
2018-06-28 |
Univ Texas |
Slc45a2 peptides for immunotherapy
|
MX2018008926A
(es)
|
2016-01-20 |
2019-01-10 |
Scripps Research Inst |
Composiciones de anticuerpo contra ror1 y métodos relacionados.
|
JP2019509023A
(ja)
|
2016-01-20 |
2019-04-04 |
ザ・スクリップス・リサーチ・インスティテュート |
Ror2抗体組成物及び関連する方法
|
CA3014792A1
(en)
|
2016-02-16 |
2017-08-24 |
Carnegie Mellon University |
Compositions for enhancing targeted gene editing and methods of use thereof
|
US20200308590A1
(en)
|
2016-02-16 |
2020-10-01 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
TW201808978A
(zh)
|
2016-03-08 |
2018-03-16 |
中央研究院 |
N-聚醣及其陣列之模組化合成方法
|
US20190046638A1
(en)
|
2016-04-01 |
2019-02-14 |
Checkmate Pharmaceuticals, Inc. |
Fc RECEPTOR-MEDIATED DRUG DELIVERY
|
EP3439692A4
(en)
|
2016-04-08 |
2020-01-22 |
ITI Health, Inc. |
ANTIBODIES BINDING PLECTIN-1 AND USES THEREOF
|
US10845367B2
(en)
|
2016-05-04 |
2020-11-24 |
Abilita Bio, Inc. |
Modified multispanning membrane polypeptides and methods of use thereof to screen therapeutic agents
|
EP3454891A4
(en)
|
2016-05-10 |
2019-12-25 |
The Regents of The University of Michigan |
EMULSION ADJUVANS FOR INTRAMUSCULAR, INTRADERMAL AND SUBCUTANEOUS ADMINISTRATION
|
CA3023672A1
(en)
|
2016-05-16 |
2017-11-23 |
Infectious Disease Research Institute |
Pegylated liposomes and methods of use
|
ES2929054T3
(es)
|
2016-05-16 |
2022-11-24 |
Access To Advanced Health Inst |
Formulación que contiene un agonista de TLR y métodos de uso
|
EP4413999A3
(en)
|
2016-05-27 |
2024-08-28 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Flt3-specific chimeric antigen receptors and methods using same
|
WO2017207623A1
(en)
|
2016-05-31 |
2017-12-07 |
Université de Lausanne |
Mirna as biomarkers and regulators of cancer stem cells
|
BR112018074352B1
(pt)
|
2016-06-01 |
2021-11-30 |
Infectious Disease Research Institute |
Partículas de nanoalume contendo um agente de dimensionamento
|
WO2018005799A1
(en)
|
2016-06-29 |
2018-01-04 |
Georgia State University Research Foundation, Inc. |
Histone deacetylase and histone methyltransferase inhibitors and methods of making and use of the same
|
US20190201414A1
(en)
|
2016-07-01 |
2019-07-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv |
Inhibitor of heme degradation for use to improve antibiotic treatment of mycobacterium tuberculosis infection
|
TWI759317B
(zh)
|
2016-07-26 |
2022-04-01 |
德商拜耳動物保健有限公司 |
牛物種中增加的生育力
|
AU2017316663B2
(en)
|
2016-08-22 |
2024-02-22 |
CHO Pharma Inc. |
Antibodies, binding fragments, and methods of use
|
WO2018049120A1
(en)
|
2016-09-09 |
2018-03-15 |
The General Hospital Corporation |
Ex vivo antigen-presenting cells or activated cd-positive t cells for treatment of cancer
|
WO2018049124A1
(en)
|
2016-09-09 |
2018-03-15 |
The General Hospital Corporation |
Hsp fusion protein with anti-chemorepellant agent for treatment of infectious disease
|
US11325951B2
(en)
|
2016-09-09 |
2022-05-10 |
The General Hospital Corporation |
HSP fusion protein with anti-chemorepellant agent for treatment of cancer
|
WO2018063472A1
(en)
|
2016-09-27 |
2018-04-05 |
Reyoung Corporation |
Compositions for treating parasitic diseases and methods thereof
|
US11725232B2
(en)
|
2016-10-31 |
2023-08-15 |
The Hong Kong University Of Science And Technology |
Compositions, methods and kits for detection of genetic variants for alzheimer's disease
|
AU2017355712B2
(en)
|
2016-11-07 |
2024-01-11 |
University Of Massachusetts |
Therapeutic targets for facioscapulohumeral muscular dystrophy
|
WO2018096396A1
(en)
|
2016-11-22 |
2018-05-31 |
University Of Oslo |
Albumin variants and uses thereof
|
US10240205B2
(en)
|
2017-02-03 |
2019-03-26 |
Population Bio, Inc. |
Methods for assessing risk of developing a viral disease using a genetic test
|
US10786471B2
(en)
|
2017-02-06 |
2020-09-29 |
Massachusetts Institute Of Technology |
Methods and products related to glutaminase inhibitors
|
CA3056797A1
(en)
|
2017-03-16 |
2018-09-20 |
Children's Medical Center Corporation |
Engineered liposomes as cancer-targeted therapeutics
|
US11547694B2
(en)
|
2017-03-23 |
2023-01-10 |
The General Hospital Corporation |
CXCR4/CXCR7 blockade and treatment of human papilloma virus-associated disease
|
US12274732B2
(en)
|
2017-03-27 |
2025-04-15 |
Tenfold Technologies, LLC |
Anti-pathogen composition and methods of use thereof
|
AU2018246232B2
(en)
|
2017-03-27 |
2023-12-07 |
Tenfold Technologies, LLC |
Methods and agricultural compositions for preventing or controlling plant diseases
|
WO2018187493A1
(en)
|
2017-04-04 |
2018-10-11 |
Yale University |
Compositions and methods for in utero delivery
|
US11225512B2
(en)
|
2017-04-27 |
2022-01-18 |
University Of New Hampshire |
Compositions and methods for ceramide-elevating therapeutic strategies
|
US11390683B2
(en)
|
2017-05-18 |
2022-07-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-mesothelin polypeptides and proteins
|
CA3066915A1
(en)
|
2017-06-11 |
2018-12-20 |
Molecular Express, Inc. |
Methods and compositions for substance use disorder vaccine formulations and uses thereof
|
KR102673794B1
(ko)
|
2017-06-15 |
2024-06-11 |
액세스 투 어드밴스드 헬스 인스티튜트 |
나노구조 지질 담체 및 안정적인 에멀션 그리고 이들의 용도
|
US11642362B2
(en)
|
2017-07-06 |
2023-05-09 |
National University Of Singapore |
Methods of inhibiting cell proliferation and METTL8 activity
|
GB201710973D0
(en)
|
2017-07-07 |
2017-08-23 |
Avacta Life Sciences Ltd |
Scaffold proteins
|
EP3651750A4
(en)
|
2017-07-14 |
2021-04-14 |
University of Massachusetts |
INFLAMMATION TREATMENT METHODS AND COMPOSITIONS
|
CA3099487A1
(en)
|
2017-07-20 |
2019-01-24 |
Nbe-Therapeutics Ag |
Human antibodies binding to ror2
|
AU2018315127B2
(en)
|
2017-08-07 |
2021-12-23 |
Nbe-Therapeutics Ag |
Anthracycline-based antibody drug conjugates having high in vivo tolerability
|
WO2019046646A1
(en)
|
2017-08-30 |
2019-03-07 |
Whole Biome Inc. |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
|
JP2020533338A
(ja)
|
2017-09-07 |
2020-11-19 |
ユニバーシティ オブ オスロUniversity of Oslo |
ワクチン分子
|
WO2019048936A1
(en)
|
2017-09-07 |
2019-03-14 |
University Of Oslo |
VACCINE MOLECULES
|
WO2019108656A1
(en)
|
2017-11-28 |
2019-06-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Microbicidal composition
|
WO2019154884A1
(en)
|
2018-02-07 |
2019-08-15 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Method for determining cancer invasiveness and patient prognosis
|
CN112119092A
(zh)
|
2018-02-12 |
2020-12-22 |
无糖尿病公司 |
改进的拮抗性抗人cd40单克隆抗体
|
US12246031B2
(en)
|
2018-02-13 |
2025-03-11 |
Checkmate Pharmaceuticals, Inc. |
Compositions and methods for tumor immunotherapy
|
EP3775218A1
(en)
|
2018-04-09 |
2021-02-17 |
Checkmate Pharmaceuticals |
Packaging oligonucleotides into virus-like particles
|
WO2019204154A1
(en)
|
2018-04-18 |
2019-10-24 |
Reyoung Corporation |
Compositions and methods for treating liver cancer
|
WO2019204614A1
(en)
|
2018-04-19 |
2019-10-24 |
Tvardi, Inc. |
Stat3 inhibitors
|
WO2019217164A1
(en)
|
2018-05-09 |
2019-11-14 |
Reyoung Corporation |
Compositions and methods for treating cancer and other diseases
|
JP2021526792A
(ja)
|
2018-06-06 |
2021-10-11 |
マサチューセッツ インスティテュート オブ テクノロジー |
真核細胞における翻訳のための環状rna
|
WO2020001657A1
(en)
|
2018-06-29 |
2020-01-02 |
Wuhan Neurophth Biological Technology Limited Company |
Compositions and methods for treating leber's hereditary optic neuropathy
|
SG11202012044QA
(en)
|
2018-06-29 |
2021-01-28 |
Wuhan Neurophth Biological Tech Limited Company |
Compositions and methods for treating leber's hereditary optic neuropathy
|
AU2019306649A1
(en)
|
2018-07-19 |
2021-02-04 |
Pendulum Therapeutics, Inc. |
Methods and compositions for microbial engraftment
|
EP4177356B1
(en)
|
2018-08-08 |
2024-05-08 |
PML Screening, LLC |
Methods for assessing risk of developing a viral disease using a genetic test
|
JP7403852B2
(ja)
|
2018-08-20 |
2023-12-25 |
ウーハン ニューロフス バイオテクノロジー リミテッド カンパニー |
レーベル遺伝性視神経症を治療するための組成物及び方法
|
EP4438618A3
(en)
|
2018-08-22 |
2025-01-01 |
Bacainn Biotherapeutics, Ltd. |
Cyclosporine compositions and methods of use
|
EP3844287B1
(en)
|
2018-08-31 |
2024-05-22 |
Yale University |
Compositions and methods for enhancing donor oligonucleotide-based gene editing
|
AU2019328326A1
(en)
|
2018-08-31 |
2021-03-18 |
Yale University |
Compositions and methods for enhancing triplex and nuclease-based gene editing
|
JP7320601B2
(ja)
|
2018-09-11 |
2023-08-03 |
上▲海▼市公共▲衛▼生▲臨▼床中心 |
広域スペクトルな抗インフルエンザワクチン免疫原及びその使用
|
JP2022508619A
(ja)
|
2018-10-04 |
2022-01-19 |
ラトガーズ, ザ ステイト ユニバーシティ オブ ニュー ジャージー |
ニューロメジンペプチドを使用して2型サイトカイン媒介性炎症を低減させる方法
|
WO2020081737A1
(en)
|
2018-10-16 |
2020-04-23 |
Massachusetts Institute Of Technology |
Compositions and methods for inducing intestinal stem cell regeneration
|
CN112912497B
(zh)
|
2018-10-19 |
2024-01-12 |
德克萨斯州大学系统董事会 |
工程化长散在元件(line)转座子及其使用方法
|
WO2020102454A1
(en)
|
2018-11-13 |
2020-05-22 |
Regents Of The University Of Minnesota |
Cd40 targeted peptides and uses thereof
|
WO2020106522A1
(en)
|
2018-11-21 |
2020-05-28 |
Tremeau Pharmaceuticals, Inc. |
Purified forms of rofecoxib, methods of manufacture and use
|
EP3677693A1
(en)
|
2019-01-03 |
2020-07-08 |
Ecole Polytechnique Federale De Lausanne (EPFL) EPFL-TTO |
Transpochimeric gene trancripts (tcgts) as cancer biomarkers
|
CN118459611A
(zh)
|
2019-01-18 |
2024-08-09 |
詹森生物科技公司 |
Gprc5d嵌合抗原受体以及表达这些受体的细胞
|
BR112021014657A2
(pt)
|
2019-01-30 |
2021-09-21 |
Janssen Pharmaceutica N.V. |
Métodos para tratar câncer de próstata com base em subtipos moleculares
|
WO2020186187A1
(en)
|
2019-03-13 |
2020-09-17 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Methods for treating bladder and urethra dysfunction and disease
|
CA3133629A1
(en)
|
2019-03-21 |
2020-09-24 |
Mitotherapeutix Llc |
Multivalent ligand clusters for targeted delivery of therapeutic agents
|
EP3952886A1
(en)
|
2019-04-10 |
2022-02-16 |
Elevatebio Technologies, Inc |
Flt3-specific chimeric antigen receptors and methods of using the same
|
SG11202112922WA
(en)
|
2019-05-22 |
2021-12-30 |
Massachusetts Inst Technology |
Circular rna compositions and methods
|
WO2020239478A1
(en)
|
2019-05-28 |
2020-12-03 |
Pharma Mar, S.A. |
Trabectedin for treating sarcomas based on genomic markers
|
WO2020257776A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
|
WO2020257779A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
|
EP3999068A1
(en)
|
2019-07-15 |
2022-05-25 |
Rovaxa |
Opioid growth factor receptor (ogfr) antagonists, in particular naloxone and/or naltrexone for treating cancer
|
CN114375302B
(zh)
|
2019-07-26 |
2024-12-24 |
詹森生物科技公司 |
包含激肽释放酶相关肽酶2抗原结合结构域的蛋白质及其用途
|
US12071466B2
(en)
|
2019-07-26 |
2024-08-27 |
Janssen Biotech, Inc. |
Anti-human kallikrein-2 (hK2) chimeric antigen receptor (CAR) and methods of use thereof
|
US20220280656A1
(en)
|
2019-07-31 |
2022-09-08 |
Yale University |
Compositions and methods for treating sickle cell disease
|
CN112390894A
(zh)
|
2019-08-12 |
2021-02-23 |
广东东阳光药业有限公司 |
嵌合抗原受体及其应用
|
WO2021030251A1
(en)
|
2019-08-12 |
2021-02-18 |
Purinomia Biotech, Inc. |
Methods and compositions for promoting and potentiating t-cell mediated immune responses through adcc targeting of cd39 expressing cells
|
KR20220041934A
(ko)
|
2019-08-16 |
2022-04-01 |
얀센 바이오테크 인코포레이티드 |
개선된 기능을 갖는 치료용 면역 세포 및 이의 제조 방법
|
JP7708436B2
(ja)
|
2019-08-30 |
2025-07-15 |
イェール ユニバーシティー |
核酸を細胞に送達するための組成物および方法
|
WO2021074695A1
(en)
|
2019-10-16 |
2021-04-22 |
Avacta Life Sciences Limited |
PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES.
|
US10945992B1
(en)
|
2019-11-13 |
2021-03-16 |
Tremeau Pharmaceuticals, Inc. |
Dosage forms of rofecoxib and related methods
|
EP4061837A1
(en)
|
2019-11-18 |
2022-09-28 |
Janssen Biotech, Inc. |
Anti-cd79 chimeric antigen receptors, car-t cells, and uses thereof
|
CN113025633B
(zh)
|
2019-12-09 |
2024-08-27 |
武汉纽福斯生物科技有限公司 |
编码人nadh脱氢酶亚单位1蛋白的核酸及其应用
|
EP3868396A1
(en)
|
2020-02-20 |
2021-08-25 |
Enthera S.R.L. |
Inhibitors and uses thereof
|
WO2021168373A1
(en)
|
2020-02-21 |
2021-08-26 |
Mitotherapeutix Llc |
Compositions and methods for inhibiting expression of methylation-controlled j-protein (mcj)
|
EP4233893A3
(en)
|
2020-03-13 |
2023-09-27 |
Janssen Biotech, Inc. |
Materials and methods for binding siglec-3/cd33
|
US20230181672A1
(en)
|
2020-05-07 |
2023-06-15 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Aberrant post-translational modifications (ptms) in methyl- and propionic acidemia and a mutant sirtuin (sirt) to metabolize ptms
|
CA3182275A1
(en)
|
2020-05-08 |
2021-11-11 |
Georgiamune Llc |
Akt3 modulators
|
MX2022014660A
(es)
|
2020-05-19 |
2023-02-16 |
Orna Therapeutics Inc |
Composiciones y métodos de arn circular.
|
TW202208418A
(zh)
|
2020-05-21 |
2022-03-01 |
美國德州系統大學評議委員會 |
具有vgll1特異性之t細胞受體及其用途
|
WO2021245285A1
(en)
|
2020-06-05 |
2021-12-09 |
Janssen Pharmaceutica Nv |
Methods of treating prostate cancer based on molecular subtypes
|
GB202101299D0
(en)
|
2020-06-09 |
2021-03-17 |
Avacta Life Sciences Ltd |
Diagnostic polypetides and methods
|
CA3190174A1
(en)
|
2020-08-03 |
2022-02-10 |
Janssen Biotech, Inc. |
Materials and methods for multidirectional biotransportation in virotherapeutics
|
CN116529266A
(zh)
|
2020-08-31 |
2023-08-01 |
耶鲁大学 |
用于将核酸递送到细胞的组合物和方法
|
AU2021337493A1
(en)
|
2020-09-04 |
2023-05-18 |
Access To Advanced Health Institute |
Co-lyophilized rna and nanostructured lipid carrier
|
EP4208195A1
(en)
|
2020-09-04 |
2023-07-12 |
Access to Advanced Health Institute |
Live-attenuated rna hybrid vaccine technology
|
AU2021335334A1
(en)
|
2020-09-04 |
2023-04-20 |
Access To Advanced Health Institute |
Genetically-adjuvanted rna vaccines
|
CN116615256A
(zh)
|
2020-10-16 |
2023-08-18 |
乔治亚大学研究基金会 |
糖缀合物
|
EP4059498A1
(en)
|
2021-03-16 |
2022-09-21 |
Centre Hospitalier Universitaire Vaudois (CHUV) |
Methods and compositions for treating conditions associated with hypermineralization
|
AU2022244453A1
(en)
|
2021-03-24 |
2023-11-09 |
Janssen Biotech, Inc. |
Antibody targeting cd22 and cd79b
|
US11161833B1
(en)
|
2021-04-09 |
2021-11-02 |
Tremeau Pharmaceuticals, Inc. |
Deuterated etoricoxib, methods of manufacture, and use thereof
|
WO2022234003A1
(en)
|
2021-05-07 |
2022-11-10 |
Avacta Life Sciences Limited |
Cd33 binding polypeptides with stefin a protein
|
WO2022237974A1
(en)
|
2021-05-12 |
2022-11-17 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Krab-containing zinc finger protein and cancer
|
CN115404240A
(zh)
|
2021-05-28 |
2022-11-29 |
上海环码生物医药有限公司 |
制备环形rna的构建体、方法及其用途
|
US20240279687A1
(en)
|
2021-06-07 |
2024-08-22 |
Yale University |
Peptide nucleic acids for spatiotemporal control of crispr-cas binding
|
WO2022271955A1
(en)
|
2021-06-23 |
2022-12-29 |
Musc Foundation For Research Development |
Novel targeted shrna nanoparticles for cancer therapy
|
CN115927472A
(zh)
|
2021-07-05 |
2023-04-07 |
武汉纽福斯生物科技有限公司 |
一种抗vegf抗体体内表达系统的构建和应用
|
EP4382601A4
(en)
|
2021-08-06 |
2025-07-30 |
Wuhan Neurophth Biotechnology Ltd Company |
COMPOSITION AND METHOD OF TREATMENT OF LEBER'S HEREDITARY OPTIC NEUROPATHY CAUSED BY THE ND4 MUTATION
|
KR20240049361A
(ko)
|
2021-08-25 |
2024-04-16 |
아이바이오, 인크. |
항-cd25 항체
|
WO2023046322A1
(en)
|
2021-09-24 |
2023-03-30 |
Janssen Pharmaceutica Nv |
Proteins comprising cd20 binding domains, and uses thereof
|
WO2023057567A1
(en)
|
2021-10-07 |
2023-04-13 |
Avacta Life Sciences Limited |
Pd-l1 binding affimers
|
US20240409638A1
(en)
|
2021-10-07 |
2024-12-12 |
Avacta Life Sciences Limited |
Serum half-life extended pd-l1 binding polypeptides
|
AU2022383068A1
(en)
|
2021-11-08 |
2024-05-02 |
Orna Therapeutics, Inc. |
Lipid nanoparticle compositions for delivering circular polynucleotides
|
CR20240196A
(es)
|
2021-11-16 |
2024-07-08 |
Shanghai Argo Biopharmaceutical Co Ltd |
Composiciones y métodos para inhibir la expresión de la proteína angiotensinógeno (agt)
|
AU2022395876A1
(en)
|
2021-11-29 |
2024-05-09 |
Shanghai Argo Biopharmaceutical Co., Ltd. |
Composition and method for inhibiting expression of hepatitis b virus (hbv) protein
|
TW202345865A
(zh)
|
2022-01-24 |
2023-12-01 |
大陸商上海舶望製藥有限公司 |
抑制LPA(Apo(a))蛋白表達的組合物和方法
|
EP4477665A4
(en)
|
2022-02-10 |
2025-08-20 |
Affyxell Therapeutics Co Ltd |
STEFIN A PROTEIN VARIANTS THAT SPECIFICALLY BIND TO CD40L AND THEIR USES
|
CN118354793A
(zh)
|
2022-04-29 |
2024-07-16 |
普瑞诺生物科技公司 |
用于治疗嗜酸性粒细胞驱动的疾病和病症的方法和组合物
|
WO2023218243A1
(en)
|
2022-05-12 |
2023-11-16 |
Avacta Life Sciences Limited |
Lag-3/pd-l1 binding fusion proteins
|
CN120092091A
(zh)
|
2022-05-30 |
2025-06-03 |
上海环码生物医药有限公司 |
合成的环状rna组合物及其使用方法
|
US12297285B2
(en)
|
2022-06-24 |
2025-05-13 |
Orna Therapeutics, Inc. |
Circular RNA encoding chimeric antigen receptors targeting BCMA
|
WO2024052882A1
(en)
|
2022-09-09 |
2024-03-14 |
Access To Advanced Health Institute |
Immunogenic vaccine composition incorporating a saponin
|
CN120112550A
(zh)
|
2022-09-09 |
2025-06-06 |
耶鲁大学 |
蛋白水解靶向抗体及其使用方法
|
WO2024081736A2
(en)
|
2022-10-11 |
2024-04-18 |
Yale University |
Compositions and methods of using cell-penetrating antibodies
|
WO2024094526A1
(en)
|
2022-11-02 |
2024-05-10 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
6-diazo-5-oxo-l-norleucine prodrugs
|
WO2024102730A1
(en)
|
2022-11-08 |
2024-05-16 |
Orna Therapeutics, Inc. |
Lipids and nanoparticle compositions for delivering polynucleotides
|
WO2024102762A1
(en)
|
2022-11-08 |
2024-05-16 |
Orna Therapeutics, Inc. |
Lipids and lipid nanoparticle compositions for delivering polynucleotides
|
PE20251853A1
(es)
|
2022-12-02 |
2025-07-22 |
Shanghai Argo Biopharmaceutical Co Ltd |
Analogos de acidos nucleicos biciclicos abasicos y compuestos oligomericos preparados a partir de estos
|
AU2023398825A1
(en)
|
2022-12-15 |
2025-06-26 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
WO2024205657A2
(en)
|
2023-03-29 |
2024-10-03 |
Orna Therapeutics, Inc. |
Lipids and lipid nanoparticle compositions for delivering polynucleotides
|
WO2024233308A2
(en)
|
2023-05-05 |
2024-11-14 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
WO2024263649A1
(en)
|
2023-06-19 |
2024-12-26 |
Yale University |
Methods and compositions for enrichment and sequencing of expansion-specific rna transcripts
|
WO2025007148A1
(en)
|
2023-06-30 |
2025-01-02 |
Orna Therapeutics, Inc. |
Polymer lipid nanoparticle compositions for delivering circular polynucleotides
|
WO2025021993A1
(en)
|
2023-07-27 |
2025-01-30 |
Omnilinx Therapeutics Ag |
Endocytic and scavenger receptor-targeting chimeric proteins and uses thereof
|
WO2025029769A1
(en)
|
2023-07-31 |
2025-02-06 |
Eli Lilly And Company |
Solid forms of a kv1.3 potassium shaker channel blockers and method of using the same
|
US11957676B1
(en)
|
2023-08-07 |
2024-04-16 |
Zetagen Therapeutics, Inc. |
Controlled release formulation and minimally invasive method of administration to locally treat cancer
|
WO2025049690A1
(en)
|
2023-08-29 |
2025-03-06 |
Orna Therapeutics, Inc. |
Circular polyethylene glycol lipids
|
WO2025052303A1
(en)
|
2023-09-08 |
2025-03-13 |
Beigene Switzerland Gmbh |
Circular rna and preparation methods thereof
|
EP4537907A1
(en)
|
2023-10-10 |
2025-04-16 |
Enthera S.r.l. |
Cd248 inhibitors and uses thereof
|
WO2025097000A1
(en)
|
2023-11-01 |
2025-05-08 |
Yale University |
Antibody-based methods for treating polycystic kidney disease
|
WO2025117969A1
(en)
|
2023-12-01 |
2025-06-05 |
Orna Therapeutics, Inc. |
Process for manufacturing lipid nanoparticles
|